Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Share-based Compensation (2020 - 2026)

Barinthus Biotherapeutics (BRNS) has disclosed Share-based Compensation for 7 consecutive years, with $556000.0 as the latest value for Q1 2026.

  • For Q1 2026, Share-based Compensation rose 18.8% year-over-year to $556000.0; the TTM value through Mar 2026 reached $556000.0, down 84.39%, while the annual FY2025 figure was $468000.0, 90.06% down from the prior year.
  • Share-based Compensation hit $556000.0 in Q1 2026 for Barinthus Biotherapeutics, down from $696000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $4.0 million in Q1 2022 and bottomed at -$415000.0 in Q3 2025.
  • Average Share-based Compensation over 5 years is $1.2 million, with a median of $1.1 million recorded in 2022.
  • Year-over-year, Share-based Compensation soared 1907.02% in 2024 and then plummeted 136.28% in 2025.
  • Barinthus Biotherapeutics' Share-based Compensation stood at $2.0 million in 2022, then tumbled by 61.49% to $786000.0 in 2023, then dropped by 3.94% to $755000.0 in 2024, then decreased by 7.81% to $696000.0 in 2025, then decreased by 20.11% to $556000.0 in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $556000.0, $696000.0, and -$415000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.